October 19, 2021 Research Bulletin

Featured Funding Opportunities

• 11/22/2021 – ADA: Leveraging Precision Medicine to Improve the Lives of People with Diabetes: Innovative Basic Science Award   
  
• 11/22/2021 – ADA: Leveraging Precision Medicine to Improve the Lives of People with Diabetes: Innovative Clinical or Translational Science
  
• 12/1/2021 – Department of the Army: DoD – USAMRAA Combat Readiness - Rapid Development and Translational Research Award
  
• 12/09/2021 – NIH - HEAL Initiative: Advancing Health Equity in Pain Management (R61/R33 Clinical Trial Required)
  
• 1/08/2022 – NIDA: Advanced Computational Approaches to Elucidate Disease Pathology and Identify Novel Therapeutics for Addiction
  
• 2/5/2022 – NIMH: Innovative Mental Health Services Research Not Involving Clinical Trials (R01 Clinical Trials Not Allowed)
  
• 2/17/2022 – NIAID: Early-Stage Development of Data Science Technologies for Infectious and Immune-mediated Diseases (U01 Clinical Trial Not Allowed)  
  
• 6/21/2022 – NIMH: Pilot Practice-based Research for Primary Care Suicide Prevention (R34 Clinical Trial Optional)
  

NIH Funding Announcements

Limited Funding Opportunities

To submit a proposal for these opportunities:

Interested candidates must send a one-page summary of their research proposal and their biosketch in pdf format via the Limited Submission Portal.

Brain Research Foundation announced seed grant opportunity for Assistant or Associate Professors

• Materials due to Internal Review Committee: November 15, 2021
• Letter of Intent: January 4, 2022
  
• Sponsor Due Date: March 30, 2022

National Institute of General Medical Sciences (NIGMS) announced the Ruth L. Kirschstein National Research Service Award (NRSA) Predoctoral Institutional Research Training Grant (T32) program

• Materials due to Internal Review Committee: November 15, 2021
  
• Sponsor Due Date: January 25, 2022

NSF has announced an opportunity - NSF National Artificial Intelligence (AI) Research Institutes

• Materials due to Internal Review Committee: November 15, 2021
  
• Sponsor Due Date Phase 1: January 14, 2022

Special Announcements

Translational Research Scholars Program (TRSP)

• The 2022 School of Medicine Translational Research Scholars Program (TRSP) will provide awards of $75K annually for up to four years.
  
• The goal of this program is to facilitate successful early career faculty in pursuing new lines of exploration and to elevate and expand the scope of their translational research.  Scholars are expected to commit 75% of their effort to scholarly activities.
  
• Applicants must have a primary appointment in a Department with the SOM, and must be working at CU Anschutz/UCHealth, Rocky Mountain VAMC, Denver Health, or National Jewish Health.
  
• Applicants must be within the first four years of their Assistant Professor appointment at the time of application (years at the Instructor level do not count against this limitation), and must hold an MD, DO, PhD, or DVM-equivalent degree.
  

Letters of Intent are due November 15, 2021.

For full details on the RFA or for additional information, contact Jennifer Kemp, PhD.

The Lorna Grindlay Moore, PhD Faculty Launch Fund

The CU Denver and CU Anschutz Medical Campus proudly announce the next call for applications for the Lorna Grindlay Moore, PhD, Faculty Launch Award.

Eligible Instructors and Assistant Professors are invited to apply for a one-year award of $40,000 to help launch their independent research programs. Faculty may be appointed in any of the schools or colleges of the CU Denver or CU Anschutz campuses whose research is centered on women’s health during and after the reproductive period.

Appropriate areas include, but are not limited to pregnancy, family planning, infertility, oncology, education, public policy, mental health, cardiovascular health, diabetes, advancing the academic careers of women faculty and the effect of COVID-19 on women’s health.

For more information visit the following Research Funding Opportunities webpage or RFA.

Due date for Letter of Intent: January 21, 2022
Due date for Applications: March 23, 2022
Funds available as of July 1, 2022

The School of Medicine’s Research Advisory Committee (RAC) is conducting a survey about human specimen biobanks on campus.

Any investigators who have or manage a human specimen biobank are requested to respond to a brief survey.

The goal is to assist investigators with biobank organization and to address the needs for increased freezer space. With information collected in the survey, the School can better shepherd resources for software database assistance, additional freezer space, and other needs.

Many of you likely remember a similar survey that was conducted prior to COVID-19. While responses were obtained, at this point some might be out-of-date and/or additional biobanks may have been established.

The RAC will be working with Melissa Haendel, PhD, Chief Research Informatics Officer (CRIO), a newly created position responsible for transforming the campus use of information and information systems, with this effort. Mary Weiser-Evans, PhD, chair of the RAC, believes that this effort should boost research efficiency and productivity by increasing multidisciplinary collaborations and elevating research capacity.

Please complete the human specimen biobank survey by October 29, 2021.

This bulletin is distributed on the 1st & 3rd Tuesday of the month for the CU Anschutz Research Community.   

Past Research Bulletins can be found here.

Please click here if you wish to be added to this distribution.